Research is required to:
This guidance:
Regulations 16 and 17 of the Biocidal Products Regulations 2001 (BPR) apply to biocidal products which are supplied or placed on the market in the UK for the purpose of process orientated research and development or experimental testing and are:
Placing a biocide on the market means a transfer of ownership to another legal entity, whether in return for payment or not.
For example:
BPR does not apply to research into active substances and biocidal products, where there is no act of supply (e.g. if you manufacture your own active ingredient and test it yourself on your own site).
Our flow diagram helps explain the requirements of UK biocides legislation in relation to experimental testing and research into the safety and efficacy of biocidal products or active substances.
In some cases a biocidal product/active substance may be placed on the market for use in an experiment or test for the purposes of research and development where there is no release to the environment (Regulation 16 of BPR). Where such a product/active substance is placed on the market for this use in UK the company must have the following information package:
Where the product/active substance is placed on the market for scientific research and development* this information package must be made available to HSE on request.
Where the product/active substance is intended for process-orientated research and development** this information package must be provided to HSE along with a completed Biocidal Products Research application form for assessment before it may be placed on the market.
In both cases if HSE consider that the experiment or test is liable to have harmful effects on humans or animals or an unacceptable adverse influence on the environment then it may prohibit the experiment or test or impose conditions considered necessary to prevent those effects.
*means scientific experimentation, analysis or chemical research carried out under controlled conditions including the determination of intrinsic properties, performance and efficacy as well as scientific investigation relating to product/active substance development
**means the further development of a substance or product in the course of which pilot plant or production trials are used to test the fields of application of that substance or product
Where a biocidal product/active substance is intended for use in any experiment or test in UK which may involve or result in the release of that product/active substance into the environment, then an experimental authorisation is required. The applicant must submit a completed Biocidal Products Research application form together with the following information to HSE:
If the application is successful the authorisation will detail conditions limiting the quantity of the biocidal product that can be used and the area that can be treated, as well as any other conditions considered necessary.
Authorisation is typically granted for a period of 12-18 months, with discretion to allow it for shorter or longer periods as appropriate.
Some examples of the areas of research that HSE has been involved in include;
It is worth considering HSE’s previously commissioned research before embarking upon any independent research.
Search the website to find research commissioned by HSE to assist in their role as the UK CA under the Biocidal Products Regulations 2001 (BPR).
Social media
Javascript is required to use HSE website social media functionality.
Follow HSE on Twitter:
Follow @H_S_E